Open Access Research Article Article ID: JVI-3-120

    Preparation and Application of two Monoclonal Antibodies against Canine Parvovirus Vaccine and Field Strains.

    Liying Hao#, Ying Wang#, Chenyu Bai, Yudan Jin, Dingding Zheng, Lingyan Chen, Xiangdong Li, Junhua Deng and Kegong Tian*

    Background: Canine parvovirus (CPV) emerged in 1970s as a highly infectious disease. PV modified live vaccines have been widely used to control the disease. It is urgent to develop specific monoclonal antibodies to differentiate field virus from vaccine virus in vaccinated dogs.

    Methods: In this study, female BALB/C mice were immunized with a commercial CPV vaccine  train. Two monoclonal antibodies (MAbs) 10H4 and 10B11 were made by hybridoma technique, and screened by hemagglutination inhibition (HI) assay.

    Results: MAb 10H4 reacted with both CPV field and vaccine strains, and MAb 10B11 only recognized field but not vaccine strains by the results of HI, indirect immunofluorescence (IFA), and virus neutralization tests.

    Conclusion: Therefore, these two MAbs may work as useful tools to study the CPV pathogenic mechanisms and to develop diagnostic reagents.

    Keywords: Canine parvovirus type 2; Monoclonal antibody; Neutralization

    Published on: May 2, 2017 Pages: 1-4

    Full Text PDF Full Text HTML DOI: 10.17352/jvi.000020
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on JVI